Ads
related to: mrna stock price forecast
Search results
Results From The WOW.Com Content Network
If we assume Moderna only hits the low end of its 2025 revenue forecast, the stock trades at roughly 9 times forward sales. That's well above the 7.2 price-to-sales ratio for the biotech industry.
There was good news to share, but the market focused on a declining sales forecast and hammered the stock lower. Last November, Moderna said it expected 2024 revenue to land in a range between $3 ...
Since cutting its 2024 revenue forecast during its second-quarter earnings 2024 call, ... Price Action: MRNA stock closed lower by 2.01% to $68.28 on Friday. ... (MRNA): Free Stock Analysis Report.
Moderna plans to cut annual research and development (R&D) spending by more than $1 billion starting in 2027 and discontinue five programs -- and it forecast that it would break even in 2028 ...
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. ... Price Action: MRNA stock is up 5.75% at $36.02 at last check Tuesday.
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so.The biggest question for investors, then, is whether ...
Ads
related to: mrna stock price forecast